HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-22FDA Approved: EMTRICITABINE — Supplemental Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s supplemental application for emtricitabine, a generic antiretroviral, finalizing changes to the product's appr…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir [Phase 1, Phase 2]
A combined Phase 1/2 clinical trial evaluating chidamide with antiretroviral therapy for eradicating latent HIV-1 reservoirs has completed.
-
FDA approval · 2020-01-14FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for emtricitabine and tenofovir disoproxil fumarate from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring [Phase 2]
A Phase 2 clinical trial update on Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring for HIV prevention and contrac…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Tesamorelin Effects on Liver Fat and Histology in HIV [NA]
Clinical trial update reporting on tesamorelin effects on liver fat and histology in HIV patients with NAFLD/NASH; study completed with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI). [Phase 4]
A Phase 4 clinical trial update exploring long-term control of viral replication in patients with primary HIV infection.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Health Improvement Project - Providence [NA]
Clinical trial update for the Health Improvement Project in HIV; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST [Phase 4]
A Phase 4 trial update announcing initiation of first-line antiretroviral treatment with tenofovir alafenamide-emtricitabine-bictegravir at …
-
FDA approval · 2020-01-07FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental ANDA for Tenofovir disoproxil fumarate from Macleods Pharmaceuticals Limited, authorizing a supplemental approva…
-
FDA approval · 2020-01-07FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Abacavir and Lamivudine from Aurobindo Pharma Limited.
-
FDA approval · 2020-01-02FDA Approved: NEVIRAPINE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Amneal Pharmaceuticals LLC's nevirapine product, updating an already approved generic antire…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)
A completed regulatory post-marketing commitment study evaluating safety and efficacy of maraviroc in CCR5-tropic HIV-1 infection with resul…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating sirolimus for reducing HIV reservoirs in individuals on suppressive ART; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission [Phase 4]
Phase 4 clinical trial evaluating two antiretroviral regimens in HIV-infected pregnant women starting ART late in pregnancy to prevent mothe…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Safety and Efficacy of Doravirine, Tenofovir, Lamivudine (MK-1439A) in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030) [Phase 2]
Phase 2 trial evaluating safety and efficacy of doravirine/tenofovir/lamivudine (MK-1439A) in treatment-naïve HIV-1 patients with transmitte…
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy [Phase 4]
Phase 4 clinical trial evaluating switching to Genvoya, followed by HCV therapy with Epclusa, and subsequent simplification to Biktarvy in H…
-
FDA approval · 2019-12-19FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie Inc., authorizing an update to the product labeling ba…
-
FDA approval · 2019-12-19FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for NORVIR (ritonavir) from AbbVie.
-
FDA approval · 2019-12-19FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie, indicating an update to its labeling.
-
FDA approval · 2019-12-19FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Metformin and Systemic Inflammation in HIV [Phase 4]
A Phase 4 clinical trial update examining the effects of metformin on systemic inflammation in individuals with HIV and prediabetes.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors [Phase 2]
Phase 2 clinical trial evaluating selective estrogen receptor modulators to enhance the reactivation of latent HIV using histone deacetylase…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda [Phase 3]
A Phase 3 trial comparing intermittent versus continuous HAART for adults with chronic HIV infection in Uganda has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Effects of Diet on Brain Processing [NA]
A completed clinical trial assessing how diet affects brain processing in people with HIV and neurocognitive impairment; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption [Phase 1]
Phase 1 trial updating vedolizumab for HIV infection under analytical treatment interruption completed with results posted in 2019.